abstract |
The present invention provides an antibody which binds to human p53 tumour suppressor protein residues 65-73 (human p53 65-73 ), as shown in SEQ ID NO: 1, when presented by the MHC class I protein Human Leukocyte Antigen-A*0201 (HLA-A*0201 ). |